Peri-Procedural Safety of GLP-1 Receptor Agonists in Elective Endoscopy: A Multicenter Retrospective Cohort Study
<b>Background and Aims</b>: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) delay gastric emptying, raising concerns about periprocedural safety in elective endoscopy. We aimed to evaluate the association between pre-procedural GLP-1 RA use and post-procedural complications such as aspiration pneumonia. <b>Methods</b>: In this retrospective cohort study, adults (18-89 years) undergoing outpatient esophagogastroduodenoscopy or colonoscopy within the HCA Healthcare network from 1 July 2021 to 31 March 2024 were identified. Patients were classified as GLP-1 RA users (<i>n</i> = 953) or non-users (<i>n</i> = 3289) based on home medication records. Primary outcomes included aspiration, post-procedural oxygen requirement, hypotension, hospitalization, ICU admission, length of stay, and all-cause inpatient mortality. Multivariable logistic and negative-binomial regression models, incorporating an interaction term for anesthesia type, were adjusted for age, sex, body mass index, ASA class, and key comorbidities. <b>Results</b>: No aspiration events were reported in either group. GLP-1 RA use was associated with lower odds of post-procedural oxygen requirement (OR 0.43, 95% CI 0.25-0.76), hospitalization (OR 0.73, 95% CI 0.39-1.36), and mortality (0.1 vs. 0.9%, <i>p</i> = 0.014), and a shorter hospital stay (IRR 0.54, 95% CI 0.40-0.71). Rates of hypotension and ICU admission were similar between both groups. In anesthesia-stratified analysis among GLP-1 RA users, those receiving MAC/MS had higher odds of hospitalization compared with GA (OR 1.87, 95% CI 1.23-2.85, <i>p</i> = 0.003), whereas other outcomes were not significant. <b>Conclusions</b>: Pre-procedural GLP-1 RA therapy was not associated with increased peri-procedural complications. Although hospitalization was more frequent with MAC/MS, this difference did not extend to other clinically significant outcomes. Further prospective studies are needed to clarify the clinical implications of anesthesia choice.
Authors
- Tony S. Brar
- Hussein A Noureldine (ORCID: https://orcid.org/0000-0002-8547-2191)
- Mohammad Abuassi (ORCID: https://orcid.org/0000-0002-9728-6310)
- Yaseen Perbtani (ORCID: https://orcid.org/0000-0002-6696-1336)
- Raghav Bassi (ORCID: https://orcid.org/0009-0003-8059-9884)
- Harsimran Kalsi (ORCID: https://orcid.org/0000-0002-3557-0500)
- Kobina Essilfie‐Quaye (ORCID: https://orcid.org/0009-0007-2159-3545)
- R. Meadows
- Carson Creamer
Institutions
- University of Central Florida (US)
- UF Health Shands Hospital (US)
- AdventHealth Orlando (US)
- University of Florida (US)
- Florida Urology Associates (US)
- Statistical Research (United States) (US)
- University of Oklahoma Health Sciences Center (US)
- Florida College (US)
Publication Details
- Journal
- Journal of Clinical Medicine
- Published
- 2025-08-30
- DOI
- https://doi.org/10.3390/jcm14176147
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- HCA Healthcare